24 related articles for article (PubMed ID: 9092852)
1. Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistance.
Schepkin VD; Lee KC; Kuszpit K; Muthuswami M; Johnson TD; Chenevert TL; Rehemtulla A; Ross BD
NMR Biomed; 2006 Dec; 19(8):1035-42. PubMed ID: 16894643
[TBL] [Abstract][Full Text] [Related]
2. Sodium and proton diffusion MRI as biomarkers for early therapeutic response in subcutaneous tumors.
Schepkin VD; Chenevert TL; Kuszpit K; Lee KC; Meyer CR; Johnson TD; Rehemtulla A; Ross BD
Magn Reson Imaging; 2006 Apr; 24(3):273-8. PubMed ID: 16563956
[TBL] [Abstract][Full Text] [Related]
3. Chip-based dynamic real-time quantification of drug-induced cytotoxicity in human tumor cells.
Wlodkowic D; Skommer J; McGuinness D; Faley S; Kolch W; Darzynkiewicz Z; Cooper JM
Anal Chem; 2009 Aug; 81(16):6952-9. PubMed ID: 19572560
[TBL] [Abstract][Full Text] [Related]
4. Chemosensitivity and resistance assays: a systematic review?
Nagourney R
J Clin Oncol; 2005 May; 23(15):3640-1; author reply 3646-8. PubMed ID: 15908685
[No Abstract] [Full Text] [Related]
5. Selection of chemotherapy for glioblastoma expressing O(6)-methylguanine-DNA methyltransferase.
Iwadate Y; Matsutani T; Hasegawa Y; Shinozaki N; Oide T; Tanizawa T; Nakatani Y; Saeki N; Fujimoto S
Exp Ther Med; 2010 Jan; 1(1):53-57. PubMed ID: 23136592
[TBL] [Abstract][Full Text] [Related]
6. Promising survival for patients with glioblastoma multiforme treated with individualised chemotherapy based on in vitro drug sensitivity testing.
Iwadate Y; Fujimoto S; Namba H; Yamaura A
Br J Cancer; 2003 Nov; 89(10):1896-900. PubMed ID: 14612899
[TBL] [Abstract][Full Text] [Related]
7. [Cancer chemo-endocrine therapy and its cell biological basis].
Nishiya I
Hum Cell; 1998 Sep; 11(3):109-14. PubMed ID: 10086273
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis in glioma cells: review and analysis of techniques used for study with focus on the laser scanning cytometer.
Amirlak B; Couldwell WT
J Neurooncol; 2003 Jun; 63(2):129-45. PubMed ID: 12825817
[TBL] [Abstract][Full Text] [Related]
9. 9L gliosarcoma cell proliferation and tumor growth in rats are suppressed by N-hydroxy-N'-(4-butyl-2-methylphenol) formamidine (HET0016), a selective inhibitor of CYP4A.
Guo M; Roman RJ; Fenstermacher JD; Brown SL; Falck JR; Arbab AS; Edwards PA; Scicli AG
J Pharmacol Exp Ther; 2006 Apr; 317(1):97-108. PubMed ID: 16352703
[TBL] [Abstract][Full Text] [Related]
10. Differential chemosensitivity in human intracerebral gliomas measured by flow cytometric DNA analysis.
Iwadate Y; Fujimoto S; Yamaura A
Int J Mol Med; 2002 Aug; 10(2):187-92. PubMed ID: 12119557
[TBL] [Abstract][Full Text] [Related]
11. Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model.
Wang X; Duan X; Yang G; Zhang X; Deng L; Zheng H; Deng C; Wen J; Wang N; Peng C; Zhao X; Wei Y; Chen L
PLoS One; 2011 Apr; 6(4):e18490. PubMed ID: 21559510
[TBL] [Abstract][Full Text] [Related]
12. Synergistic cytotoxicity of the ribonucleotide reductase inhibitor didox (3,4-dihydroxy-benzohydroxamic acid) and the alkylating agent carmustine (BCNU) in 9L rat gliosarcoma cells and DAOY human medulloblastoma cells.
Horvath Z; Höchtl T; Bauer W; Fritzer-Szekeres M; Elford HL; Szekeres T; Tihan T
Cancer Chemother Pharmacol; 2004 Aug; 54(2):139-45. PubMed ID: 15133626
[TBL] [Abstract][Full Text] [Related]
13. [Chemosensitivity assays for malignant gliomas].
Sasaoka N
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2247-52. PubMed ID: 2241189
[TBL] [Abstract][Full Text] [Related]
14. Prediction of drug cytotoxicity in 9L rat brain tumor by using flow cytometry with a deoxyribonucleic acid-binding dye.
Iwadate Y; Fujimoto S; Sueyoshi K; Namba H; Tagawa M; Yamaura A
Neurosurgery; 1997 Apr; 40(4):782-7; discussion 787-8. PubMed ID: 9092852
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
